A double-blind controlled study of pipothiazine palmitate in the maintenance treatment of schizophrenic outpatients.

Categoría Estudio primario
RevistaJournal of clinical pharmacology
Año 1978
Cargando información sobre las referencias
In a double-blind controlled study lasting 9 months, pipothiazine palmitate, a long-acting neuroleptic that can be administered intramuscularly once a month, was compared with fluphenazine enanthate in the maintenance treatment of 32 schizophrenic outpatients. Before the trial commenced, all patients were being treated with fluphenazine enanthate. The results indicate that pipothiazine palmitate was not as potent a neuroleptic as fluphenazine enanthate. Pipothiazine appears to resemble fluphenazine enanthate in its capacity to induce parkinsonism and tardive dyskinesia.
Epistemonikos ID: 0d0266fa94162d414800d8b3b7cf9f7d032b1acc
First added on: Apr 14, 2014